Global Glucagon Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Glucagon Drug market size was valued at USD 3757.7 million in 2022 and is forecast to a readjusted size of USD 5554.7 million by 2029 with a CAGR of 5.7% during review period.

Glucagon is a prescription drug for injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Glucagon Drug industry chain, the market status of Emergency Kits (Inject Glucagon, Nasal Glucagon), General Use (Inject Glucagon, Nasal Glucagon), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glucagon Drug.

Regionally, the report analyzes the Glucagon Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glucagon Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Glucagon Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glucagon Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inject Glucagon, Nasal Glucagon).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glucagon Drug market.

Regional Analysis: The report involves examining the Glucagon Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glucagon Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Glucagon Drug:
Company Analysis: Report covers individual Glucagon Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glucagon Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Emergency Kits, General Use).

Technology Analysis: Report covers specific technologies relevant to Glucagon Drug. It assesses the current state, advancements, and potential future developments in Glucagon Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glucagon Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Glucagon Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Inject Glucagon
    Nasal Glucagon

Market segment by Application
    Emergency Kits
    General Use
    Diagnostic & Motility
    Cardiogenic Shock
    Others

Major players covered
    Novo Nordisk
    Eli Lilly
    Fresenius Kabi
    Torrent Labs

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon Drug, with price, sales, revenue and global market share of Glucagon Drug from 2018 to 2023.
Chapter 3, the Glucagon Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Glucagon Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon Drug.
Chapter 14 and 15, to describe Glucagon Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Glucagon Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Glucagon Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Inject Glucagon
        1.3.3 Nasal Glucagon
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Glucagon Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Emergency Kits
        1.4.3 General Use
        1.4.4 Diagnostic & Motility
        1.4.5 Cardiogenic Shock
        1.4.6 Others
    1.5 Global Glucagon Drug Market Size & Forecast
        1.5.1 Global Glucagon Drug Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Glucagon Drug Sales Quantity (2018-2029)
        1.5.3 Global Glucagon Drug Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk Glucagon Drug Product and Services
        2.1.4 Novo Nordisk Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 Eli Lilly
        2.2.1 Eli Lilly Details
        2.2.2 Eli Lilly Major Business
        2.2.3 Eli Lilly Glucagon Drug Product and Services
        2.2.4 Eli Lilly Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Eli Lilly Recent Developments/Updates
    2.3 Fresenius Kabi
        2.3.1 Fresenius Kabi Details
        2.3.2 Fresenius Kabi Major Business
        2.3.3 Fresenius Kabi Glucagon Drug Product and Services
        2.3.4 Fresenius Kabi Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Fresenius Kabi Recent Developments/Updates
    2.4 Torrent Labs
        2.4.1 Torrent Labs Details
        2.4.2 Torrent Labs Major Business
        2.4.3 Torrent Labs Glucagon Drug Product and Services
        2.4.4 Torrent Labs Glucagon Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Torrent Labs Recent Developments/Updates

3 Competitive Environment: Glucagon Drug by Manufacturer
    3.1 Global Glucagon Drug Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Glucagon Drug Revenue by Manufacturer (2018-2023)
    3.3 Global Glucagon Drug Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Glucagon Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Glucagon Drug Manufacturer Market Share in 2022
        3.4.2 Top 6 Glucagon Drug Manufacturer Market Share in 2022
    3.5 Glucagon Drug Market: Overall Company Footprint Analysis
        3.5.1 Glucagon Drug Market: Region Footprint
        3.5.2 Glucagon Drug Market: Company Product Type Footprint
        3.5.3 Glucagon Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Glucagon Drug Market Size by Region
        4.1.1 Global Glucagon Drug Sales Quantity by Region (2018-2029)
        4.1.2 Global Glucagon Drug Consumption Value by Region (2018-2029)
        4.1.3 Global Glucagon Drug Average Price by Region (2018-2029)
    4.2 North America Glucagon Drug Consumption Value (2018-2029)
    4.3 Europe Glucagon Drug Consumption Value (2018-2029)
    4.4 Asia-Pacific Glucagon Drug Consumption Value (2018-2029)
    4.5 South America Glucagon Drug Consumption Value (2018-2029)
    4.6 Middle East and Africa Glucagon Drug Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Glucagon Drug Sales Quantity by Type (2018-2029)
    5.2 Global Glucagon Drug Consumption Value by Type (2018-2029)
    5.3 Global Glucagon Drug Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Glucagon Drug Sales Quantity by Application (2018-2029)
    6.2 Global Glucagon Drug Consumption Value by Application (2018-2029)
    6.3 Global Glucagon Drug Average Price by Application (2018-2029)

7 North America
    7.1 North America Glucagon Drug Sales Quantity by Type (2018-2029)
    7.2 North America Glucagon Drug Sales Quantity by Application (2018-2029)
    7.3 North America Glucagon Drug Market Size by Country
        7.3.1 North America Glucagon Drug Sales Quantity by Country (2018-2029)
        7.3.2 North America Glucagon Drug Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Glucagon Drug Sales Quantity by Type (2018-2029)
    8.2 Europe Glucagon Drug Sales Quantity by Application (2018-2029)
    8.3 Europe Glucagon Drug Market Size by Country
        8.3.1 Europe Glucagon Drug Sales Quantity by Country (2018-2029)
        8.3.2 Europe Glucagon Drug Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Glucagon Drug Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Glucagon Drug Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Glucagon Drug Market Size by Region
        9.3.1 Asia-Pacific Glucagon Drug Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Glucagon Drug Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Glucagon Drug Sales Quantity by Type (2018-2029)
    10.2 South America Glucagon Drug Sales Quantity by Application (2018-2029)
    10.3 South America Glucagon Drug Market Size by Country
        10.3.1 South America Glucagon Drug Sales Quantity by Country (2018-2029)
        10.3.2 South America Glucagon Drug Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Glucagon Drug Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Glucagon Drug Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Glucagon Drug Market Size by Country
        11.3.1 Middle East & Africa Glucagon Drug Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Glucagon Drug Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Glucagon Drug Market Drivers
    12.2 Glucagon Drug Market Restraints
    12.3 Glucagon Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Glucagon Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Glucagon Drug
    13.3 Glucagon Drug Production Process
    13.4 Glucagon Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Glucagon Drug Typical Distributors
    14.3 Glucagon Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Glucagon Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Glucagon Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 4. Novo Nordisk Major Business
    Table 5. Novo Nordisk Glucagon Drug Product and Services
    Table 6. Novo Nordisk Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Novo Nordisk Recent Developments/Updates
    Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 9. Eli Lilly Major Business
    Table 10. Eli Lilly Glucagon Drug Product and Services
    Table 11. Eli Lilly Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Eli Lilly Recent Developments/Updates
    Table 13. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
    Table 14. Fresenius Kabi Major Business
    Table 15. Fresenius Kabi Glucagon Drug Product and Services
    Table 16. Fresenius Kabi Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Fresenius Kabi Recent Developments/Updates
    Table 18. Torrent Labs Basic Information, Manufacturing Base and Competitors
    Table 19. Torrent Labs Major Business
    Table 20. Torrent Labs Glucagon Drug Product and Services
    Table 21. Torrent Labs Glucagon Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Torrent Labs Recent Developments/Updates
    Table 23. Global Glucagon Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 24. Global Glucagon Drug Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 25. Global Glucagon Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 26. Market Position of Manufacturers in Glucagon Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 27. Head Office and Glucagon Drug Production Site of Key Manufacturer
    Table 28. Glucagon Drug Market: Company Product Type Footprint
    Table 29. Glucagon Drug Market: Company Product Application Footprint
    Table 30. Glucagon Drug New Market Entrants and Barriers to Market Entry
    Table 31. Glucagon Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 32. Global Glucagon Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 33. Global Glucagon Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 34. Global Glucagon Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 35. Global Glucagon Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 36. Global Glucagon Drug Average Price by Region (2018-2023) & (US$/Unit)
    Table 37. Global Glucagon Drug Average Price by Region (2024-2029) & (US$/Unit)
    Table 38. Global Glucagon Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 39. Global Glucagon Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 40. Global Glucagon Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 41. Global Glucagon Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 42. Global Glucagon Drug Average Price by Type (2018-2023) & (US$/Unit)
    Table 43. Global Glucagon Drug Average Price by Type (2024-2029) & (US$/Unit)
    Table 44. Global Glucagon Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 45. Global Glucagon Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 46. Global Glucagon Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 47. Global Glucagon Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 48. Global Glucagon Drug Average Price by Application (2018-2023) & (US$/Unit)
    Table 49. Global Glucagon Drug Average Price by Application (2024-2029) & (US$/Unit)
    Table 50. North America Glucagon Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 51. North America Glucagon Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 52. North America Glucagon Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 53. North America Glucagon Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 54. North America Glucagon Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 55. North America Glucagon Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 56. North America Glucagon Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 57. North America Glucagon Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 58. Europe Glucagon Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 59. Europe Glucagon Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 60. Europe Glucagon Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 61. Europe Glucagon Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 62. Europe Glucagon Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 63. Europe Glucagon Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 64. Europe Glucagon Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 65. Europe Glucagon Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 66. Asia-Pacific Glucagon Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 67. Asia-Pacific Glucagon Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 68. Asia-Pacific Glucagon Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 69. Asia-Pacific Glucagon Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 70. Asia-Pacific Glucagon Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 71. Asia-Pacific Glucagon Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 72. Asia-Pacific Glucagon Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 73. Asia-Pacific Glucagon Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 74. South America Glucagon Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 75. South America Glucagon Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 76. South America Glucagon Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 77. South America Glucagon Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 78. South America Glucagon Drug Sales Quantity by Country (2018-2023) & (K Units)
    Table 79. South America Glucagon Drug Sales Quantity by Country (2024-2029) & (K Units)
    Table 80. South America Glucagon Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 81. South America Glucagon Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 82. Middle East & Africa Glucagon Drug Sales Quantity by Type (2018-2023) & (K Units)
    Table 83. Middle East & Africa Glucagon Drug Sales Quantity by Type (2024-2029) & (K Units)
    Table 84. Middle East & Africa Glucagon Drug Sales Quantity by Application (2018-2023) & (K Units)
    Table 85. Middle East & Africa Glucagon Drug Sales Quantity by Application (2024-2029) & (K Units)
    Table 86. Middle East & Africa Glucagon Drug Sales Quantity by Region (2018-2023) & (K Units)
    Table 87. Middle East & Africa Glucagon Drug Sales Quantity by Region (2024-2029) & (K Units)
    Table 88. Middle East & Africa Glucagon Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 89. Middle East & Africa Glucagon Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 90. Glucagon Drug Raw Material
    Table 91. Key Manufacturers of Glucagon Drug Raw Materials
    Table 92. Glucagon Drug Typical Distributors
    Table 93. Glucagon Drug Typical Customers
List of Figures
    Figure 1. Glucagon Drug Picture
    Figure 2. Global Glucagon Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Glucagon Drug Consumption Value Market Share by Type in 2022
    Figure 4. Inject Glucagon Examples
    Figure 5. Nasal Glucagon Examples
    Figure 6. Global Glucagon Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Glucagon Drug Consumption Value Market Share by Application in 2022
    Figure 8. Emergency Kits Examples
    Figure 9. General Use Examples
    Figure 10. Diagnostic & Motility Examples
    Figure 11. Cardiogenic Shock Examples
    Figure 12. Others Examples
    Figure 13. Global Glucagon Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Glucagon Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Glucagon Drug Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Glucagon Drug Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Glucagon Drug Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Glucagon Drug Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Glucagon Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Glucagon Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Glucagon Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Glucagon Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Glucagon Drug Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Glucagon Drug Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Glucagon Drug Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Glucagon Drug Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Glucagon Drug Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Glucagon Drug Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Glucagon Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Glucagon Drug Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Glucagon Drug Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Glucagon Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Glucagon Drug Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Glucagon Drug Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Glucagon Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Glucagon Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Glucagon Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Glucagon Drug Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Glucagon Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Glucagon Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Glucagon Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Glucagon Drug Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Glucagon Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Glucagon Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Glucagon Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Glucagon Drug Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Glucagon Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Glucagon Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Glucagon Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Glucagon Drug Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Glucagon Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Glucagon Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Glucagon Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Glucagon Drug Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Glucagon Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Glucagon Drug Market Drivers
    Figure 76. Glucagon Drug Market Restraints
    Figure 77. Glucagon Drug Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Glucagon Drug in 2022
    Figure 80. Manufacturing Process Analysis of Glucagon Drug
    Figure 81. Glucagon Drug Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs